Luye Pharmaceutical Group
Manufacturing · China · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
22f Gubei International Fortune Center P...Phone Number
(609) 799-7600Website
www.luye.cnRevenue
$843.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Luye Pharmaceutical Group
Luye Pharma Group is an international pharmaceutical company with a focus on targeting central nervous system (CNS), oncology and other therapeutic areas. Global R&D, global manufacturing, and the global sale of innovative medications are the company’s three main strategic priorities. The group was founded in 1994 and is headquartered in Shanghai, China.Explore more
Luye Pharmaceutical Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Luye Pharmaceutical Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Luye Pharmaceutical Group is spiking on competitors!
Luye Pharmaceutical Group, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Luye Pharmaceutical Group launches new products
Check if Luye Pharmaceutical Group has recently received funding, and reach out quickly before it becomes old news!
Click to see if Luye Pharmaceutical Group had a recent Job posting/layoffs
Earning: See what the market has to say on Luye Pharmaceutical Group recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Luye Pharmaceutical Group
Funding: Get notified immidiatlly once Luye Pharmaceutical Group has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Luye Pharmaceutical Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Luye Pharmaceutical Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Luye Pharmaceutical Group.
Luye Pharmaceutical Group Tech Stack
A closer look at the technologies used by Luye Pharmaceutical Group
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Luye Pharmaceutical Group has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Areas of expertise include: Customer Relationship Management, Pharmaceutical Manufacturing, Research Reports, and Product Definition.
Hiring Plans
Hiring Plans
Luye Pharmaceutical Group has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Areas of expertise include: Pharmaceutical Manufacturing, Research Reports, Product Definition, and Customer Relationship Management.
Hiring Plans
Hiring Plans
Luye Pharmaceutical Group has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Luye Pharmaceutical Group News & Media
Luye Pharma Announces U.S. Launch of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Schizoaffective Disorder
PRINCETON, N.J., April 6, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI® (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in the U.S. for the treatment of adults with schizophrenia and as a monotherapy or adjunct...Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer's Dementia
TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry of Health, Labour and Welfare as a new drug, indicated for suppression of progression of dementia symptoms in mild to moderate Alzheimer's disease. The product is to be marketed as Rivaluen® LA Patch 25.92mg/51.84mg. It is the first extended-release Rivastigmine transdermal formulationLuye Pharma Announces U.S. FDA Approval of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for Treating Schizophrenia and Schizoaffective Disorder
PRINCETON, N.J., July 28, 2024 /PRNewswire/ -- Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sales of innovative medications, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's...NDA for Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Filed in Japan for Treating Alzheimer's Dementia
TOKYO, June 6, 2024 /PRNewswire/ -- Luye Pharma Group announced that its partner Towa Pharmaceutical Co., Ltd. (Towa) has filed a New Drug Application (NDA) to the Ministry of Health, Labour and Welfare (MHLW) in Japan for the Rivastigmine Twice Weekly Transdermal Patch for treating mild to moderate dementia associated with Alzheimer's disease. The drug was developed by Luye Pharma on its proprietary transdermal patch platform, utilizing an innovative drug delivery system to administer rivastigm
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Luye Pharmaceutical Group
Sign Up For FreeTo access detailed company insights
Luye Pharma Group is an international pharmaceutical company with a focus on targeting central nervous system (CNS), oncology and other therapeutic areas. Global R&D, global manufacturing, and the global sale of innovative medications are the company’s three main strategic priorities. The group was founded in 1994 and is headquartered in Shanghai,... Read More
